Showing results (821-830 of 925) with videos related to

Sort By:
Pageof 93
Human Molecular Genetics|March 17, 2006
Cell mixing at a neural crest-mesoderm boundary and deficient ephrin-Eph signaling in the pathogenesis of craniosynostosisAmy E Merrill, Elena G Bochukova, Sean M Brugger, et al.
The American Journal of Psychiatry|August 30, 2018
Attenuation of Antidepressant Effects of Ketamine by Opioid Receptor AntagonismNolan R Williams, Boris D Heifets, Christine Blasey, et al.
Environmental Research|October 20, 2019
Microplastic-induced damage in early embryonal development of sea urchin Sphaerechinus granularisMarco Trifuoggi, Giovanni Pagano, Rahime Oral, et al.
Journal of Cell Communication and Signaling|May 14, 2013
CCN2/CTGF is required for matrix organization and to protect growth plate chondrocytes from cellular stressFaith Hall-Glenn, Armen Aivazi, Lusi Akopyan, et al.
BMC Pregnancy and Childbirth|September 24, 2021
Patient decision aid for trial of labor after cesarean (TOLAC) versus planned repeat cesarean delivery: a quasi-experimental pre-post studyKartik K Venkatesh, Suzanne Brodney, Michael J Barry, et al.
Materials (Basel, Switzerland)|July 27, 2022
Clinical and Microbiological Evaluation of a Chlorhexidine-Modified Glass Ionomer Cement (GIC-CHX) Restoration Placed Using the Atraumatic Restorative Treatment (ART) TechniqueJithendra Ratnayake, Arthi Veerasamy, Hassan Ahmed, et al.
Applied Mathematics|December 20, 2014
Automated Cell Detection and Morphometry on Growth Plate Images of Mouse BoneMaria-Grazia Ascenzi, Xia Du, James I Harding, et al.
Frontiers in Bioengineering and Biotechnology|March 4, 2024
Novel bisphosphonate-based cathepsin K-triggered compound targets the enthesis without impairing soft tissue-to-bone healingBrendan Y Shi, Varun Sriram, Shannon Y Wu, et al.
Urology|February 1, 2003
Quality of life after a diagnosis of prostate cancer among men of lower socioeconomic status: results from the Veterans Affairs Cancer of the Prostate Outcomes StudyAmy K Siston, Sara J Knight, Nicholas P Slimack, et al.
British Journal of Haematology|August 31, 2019
A phase II study of addition of pracinostat to a hypomethylating agent in patients with myelodysplastic syndromes who have not responded to previous hypomethylating agent therapyFevzi F Yalniz, Jesus G Berdeja, Michael B Maris, et al.
Pageof 93